{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T06:30:23Z","timestamp":1648794623419},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.mehy.2005.08.056","type":"journal-article","created":{"date-parts":[[2005,12,3]],"date-time":"2005-12-03T12:17:04Z","timestamp":1133612224000},"page":"509-512","source":"Crossref","is-referenced-by-count":4,"title":["Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"66","author":[{"given":"Rodney E.","family":"Shackelford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami R.","family":"Bhalodia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Cotelingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana M.","family":"Veillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Lowery-Nordberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2005.08.056_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.mehy.2005.08.056_bib2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood.V86.3.1163.1163","article-title":"True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases","volume":"86","author":"Hoyer","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2005.08.056_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s001090050350","article-title":"Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis","volume":"77","author":"Dohner","year":"1999","journal-title":"J Mol Med"},{"key":"10.1016\/j.mehy.2005.08.056_bib4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.leu.2402537","article-title":"Chronic lymphocytic leukemia.Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course","volume":"16","author":"Stilgenbauer","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.mehy.2005.08.056_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2141.2004.05344.x","article-title":"Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia","volume":"128","author":"Dickinson","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mehy.2005.08.056_bib6","first-page":"908","article-title":"Deletions at 11q23 in different lymphoma subtypes","volume":"85","author":"Zhu","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.mehy.2005.08.056_bib7","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2000.18.13.2607","article-title":"Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin\u2019s lymphoma: correlation with clinicobiologic features","volume":"18","author":"Cuneo","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mehy.2005.08.056_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/beha.2000.0119","article-title":"Biology and therapy of secondary leukemias","volume":"l14","author":"Dann","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.mehy.2005.08.056_bib9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.dnarep.2004.03.029","article-title":"DNA damage-induced activation of ATM and ATM-dependent signaling pathways","volume":"3","author":"Kurz","year":"2004","journal-title":"DNA Repair"},{"key":"10.1016\/j.mehy.2005.08.056_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbrc.2005.03.211","article-title":"Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer","volume":"331","author":"Artandi","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2005.08.056_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00001622-200401000-00006","article-title":"Chromosomal instability","volume":"16","author":"Gollin","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.mehy.2005.08.056_bib12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.dnarep.2004.04.010","article-title":"Ataxia-telangiectasia, an evolving phenotype","volume":"3","author":"Chun","year":"2004","journal-title":"DNA Repair"},{"key":"10.1016\/j.mehy.2005.08.056_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V94.2.748","article-title":"Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia","volume":"94","author":"Schaffner","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2005.08.056_bib14","first-page":"4552","article-title":"Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia","volume":"58","author":"Starostik","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2005.08.056_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cancergencyto.2003.10.010","article-title":"Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders","volume":"152","author":"Eclache","year":"2004","journal-title":"Cancer Genet Cytogen"},{"key":"10.1016\/j.mehy.2005.08.056_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1182\/blood.V99.1.300","article-title":"Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage","volume":"99","author":"Stankovic","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2005.08.056_bib17","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/sj.leu.2402540","article-title":"Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)","volume":"16","author":"Faderl","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.mehy.2005.08.056_bib18","first-page":"44","article-title":"Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance","volume":"87","author":"Cuneo","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.mehy.2005.08.056_bib19","unstructured":"Shackelford RE, Fu Y, Brooks TC, Manuszak RP, Sequeira AP, Wang S, et al. Iron chelators reduce spontaneous double-stranded DNA breaks in ataxia-telangiectasia cells. DNA Repair, in press."},{"key":"10.1016\/j.mehy.2005.08.056_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000163692","article-title":"Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways","volume":"60","author":"Seligman","year":"1992","journal-title":"Pathobiology"},{"key":"10.1016\/j.mehy.2005.08.056_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/00365519309090703","article-title":"The transferrin receptor: its diagnostic value and its potential as therapeutic target","volume":"215","author":"Thorstensen","year":"1993","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.mehy.2005.08.056_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000163610","article-title":"Regulation of transferrin receptor expression and control of cell growth","volume":"59","author":"Neckers","year":"1991","journal-title":"Pathobiology"},{"key":"10.1016\/j.mehy.2005.08.056_bib23","unstructured":"Smilevska T, Stamatopoulos K, Samara M, Belessi C, Tsompanakou A, Paterakis G, et al. Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia. Leuk Res [Epub ahead of print]."},{"key":"10.1016\/j.mehy.2005.08.056_bib24","first-page":"2019","article-title":"Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia","volume":"7","author":"Beguin","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.mehy.2005.08.056_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1620\/tjem.205.297","article-title":"Aquisition, mobilization and utilization of cellular iron and heme: endless findings and growing evidence of tight regulation","volume":"205","author":"Taketani","year":"2005","journal-title":"Tohoku J Exp Med"},{"issue":"Suppl. 10","key":"10.1016\/j.mehy.2005.08.056_bib26","first-page":"39","article-title":"Apoptotic mechanisms of gallium nitrate: basic and clinical investigations","volume":"13","author":"Chitambar","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.mehy.2005.08.056_bib27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1517\/13543784.13.5.531","article-title":"Gallium nitrate for the treatment of non-Hodgkin\u2019s lymphoma","volume":"13","author":"Chitambar","year":"2004","journal-title":"Expert Opin Inv Drug"},{"key":"10.1016\/j.mehy.2005.08.056_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/srao.2001.26030","article-title":"ATM as a target for novel radiosensitizers","volume":"11","author":"Sarkaria","year":"2001","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.mehy.2005.08.056_bib29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.moh.0000138682.13354.da","article-title":"Mantle cell lymphoma","volume":"11","author":"Bertoni","year":"2004","journal-title":"Curr Opin Hematol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705005116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705005116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T09:55:19Z","timestamp":1586598919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987705005116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0306987705005116"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2005.08.056","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}